Hepatic Dose Adjustment Guide

Enter five clinical parameters to calculate a Child-Pugh score, classify hepatic impairment severity, and review general dose adjustment guidance.

Child-Pugh Parameters

Select the value that best matches the patient's clinical status.

Disclaimer: For educational reference only. Always verify against official prescribing information and consult a licensed clinician before adjusting doses.

Child-Pugh Score

/ 15

Select parameters and click Calculate

5 pts — Class A 10 pts — Class C 15 pts

General Dose Adjustment Guidance

Results will appear here after calculation.

Common Hepatically-Cleared Drugs

General patterns only — always check the full prescribing information.

Drug Class A Class B Class C
Acetaminophen Normal dose; limit duration Reduce dose; max 2 g/day Avoid if possible
Atorvastatin Normal dose Use with caution; monitor LFTs Contraindicated
Metoprolol Normal dose Reduce; start at 25% of normal Reduce; 12.5%–25% of normal
Warfarin Normal; close INR monitoring Reduce dose; frequent INR checks Avoid or use very low doses with intensive monitoring
Morphine Normal; monitor closely Reduce 25–50%; longer intervals Reduce 50%+; risk of encephalopathy
Diazepam Normal; monitor sedation Reduce dose significantly Avoid; precipitates encephalopathy
Propranolol Normal dose Reduce by 50%; monitor Reduce substantially; careful titration
Rifampicin Use with caution Reduce to 50% of normal dose Avoid

Summary

Enter five clinical parameters to calculate a Child-Pugh score, classify hepatic impairment severity, and review general dose adjustment guidance.

How it works

  1. Enter the five Child-Pugh parameters: bilirubin, albumin, PT prolongation, ascites, and encephalopathy.
  2. Each parameter scores 1–3 points based on clinical thresholds.
  3. Total points (5–15) map to Class A (5–6), Class B (7–9), or Class C (10–15).
  4. The tool displays the class and general dose adjustment guidance for each severity level.
  5. Review the drug-specific notes table for common hepatically-cleared medications.

Use cases

  • Estimate safe starting doses for patients with known liver disease.
  • Classify hepatic impairment severity before prescribing hepatically-metabolized drugs.
  • Support clinical pharmacy reviews for patients with cirrhosis.
  • Educate students and trainees on Child-Pugh scoring methodology.
  • Cross-reference with drug labeling guidance for Child-Pugh Class B or C patients.

Frequently Asked Questions

Last updated: 2026-07-23 · Reviewed by Nham Vu